Antivenom Market Will Reach 1020 Million US$ by 2025

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.

Logo

City of Industry, CA -- (SBWire) -- 10/01/2018 --This report studies the global Antivenom market status and forecast, categorizes the global Antivenom market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.

The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.

Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.

The global Antivenom market is valued at 830 million US$ in 2017 and will reach 1020 million US$ by the end of 2025, growing at a CAGR of 2.6% during 2018-2025.

The major manufacturers covered in this report

CSL Behring

Merck & Co., Inc.

BTG Plc

Pfizer

Haffkine Bio-Pharmaceutical Corporation

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/61104/global-antivenom-market

Market size split by Region
North America
Asia-Pacific
Europe
Central & South America
Middle East & Africa

Buy Full Antivenom Market Report Now, Report delivery time within 24 hours https://www.qyresearch.com/settlement/pre/3c114a1304db80a184d9f478af2bd0e4,0,1,Global%20Antivenom%20Market%20Professional%20Survey%20Report%202018

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, INC.
1-626-295-2442
https://www.qyresearch.com

View this press release online at: http://rwire.com/1056970